Recent studies have revealed that SEMA3B could be a tumor suppressor in various cancer types, including lung cancer, breast cancer, and esophageal squamous cell carcinoma [58, 59]. This evidence concerns the gene SEMA3B and esophageal squamous cell carcinoma.